Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 50 /hr
Hire Dr. Sandhya B.
United States
USD 50 /hr
Transplant immunologist with research experience in molecular biology, microbiology, biochemistry and drug discovery.
Profile Summary
Subject Matter Expertise
Services
Writing
Clinical Trial Documentation,
Technical Writing,
Copywriting,
Newswriting
Research
Market Research,
User Research,
Meta-Research,
Feasibility Study,
Fact Checking,
Gap Analysis,
Gray Literature Search,
Systematic Literature Review,
Secondary Data Collection
Consulting
Digital Strategy Consulting,
Scientific and Technical Consulting,
Regulatory Consulting
Data & AI
Statistical Analysis,
Data Visualization,
Big Data Analytics,
Data Processing,
Data Insights
Product Development
Formulation,
Stability/Shelf Life Testing,
Product Evaluation,
Material Sourcing,
Product Validation,
Manufacturing,
Concept Development,
Prototyping
Work Experience
Dignity Health
July 2016 - Present 
Postdoctoral Fellow
University of Illinois at Urbana Champaign
July 2015 - July 2016
Postdoctoral fellow
Regional Centre for Biotechnology
April 2012 - June 2015
Education
PhD
Dr. B.R Ambedkar Center for Biomedical Research
July 2005 - July 2012
M.Sc
Dr B R Ambedkar center for Biomedical Research
July 2003 - June 2005
B.Sc , Biochemistry
Kurukshetra University
June 2000 - June 2003
Certifications
- Certification details not provided.
Publications
JOURNAL ARTICLE
(2020). Decline in Club Cell Secretory Proteins, Exosomes Induction and Immune Responses to Lung Self-antigens, Kα1 Tubulin and Collagen V, Leading to Chronic Rejection after Human Lung Transplantation . Transplantation.
(2020). The role of miRNA-155 in the immunopathogenesis of obliterative airway disease in mice induced by circulating exosomes from human lung transplant recipients with chronic lung allograft dysfunction . Cellular immunology.
(2020). Global Proteomics Analysis of Circulating Extracellular Vesicles Isolated from Lung Transplant Recipients . ACS omega.
(2020). Respiratory viral infection in lung transplantation induces exosomes that trigger chronic rejection . The Journal of Heart and Lung Transplantation.
(2019). The role of donor-derived exosomes in lung allograft rejection . Human Immunology.
(2019). A novel mechanism for immune regulation after human lung transplantation . The Journal of Thoracic and Cardiovascular Surgery.
(2019). The detection of donor-derived cell-free DNA may serve as a biomarker for the early detection of chronic lung allograft dysfunction . EBioMedicine.
(2019). Benzimidazoles: Selective inhibitors of Topoisomerase I with Differential mode of action. Biochemistry.
(2018). The Role of Exosomes in Allograft Immunity. Cellular immunology.
(2018). Bisphosphonate-Generated ATP-Analogs Inhibit Cell Signaling Pathways. J Am Chem Soc.
(2018). Tissue-associated self-antigens containing exosomes: Role in allograft rejection. Hum Immunol.
(2017). Pulsed Electron Paramagnetic Resonance Insights into the Ligand Environment of Copper in Drosophila Lysyl Oxidase. Biochemistry.
(2017). Topoisomerases Resistance vs Sensitivity: How far we can go?. Med Res Rev.
(2017). Deciphering the Role of Hydrophobic and Hydrophilic Bile Acids in Angiogenesis using in vitro and in vivo Model Systems. Med Chem Comm.
(2016). Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation.
(2015). Nature of the charged head group dictates the anticancer potential of Lithocholic acid-Tamoxifen conjugates for breast cancer therapy. Med. Chem. Commun.
(2015). Cell-penetrating Synthetic Antimicrobial Polypeptides (SAMPs) exhibiting potent and selective killing of Mycobacterium by targeting its DNA. Chemistry: A Europeon Journal. 2015; 21(9):3540-5.
(2015). Nature of the charged head group dictates the anticancer potential of Lithocholic acid-Tamoxifen conjugates for breast cancer therapy. Med. Chem. Commun 2015, 6, 778-787.
(2015). Synthesis, structure–activity relationship, and mechanistic investigation of lithocholic acid amphiphiles for colon cancer therapy. Med. Chem. Commun., 2015, 6, 192-201.
(2014). Bile acid amphiphiles with tunable head groups as highly selective antitubercular agents. Med. Chem. Commun., 2014, 5, 1761-1768.
(2013). Design, synthesis, and mechanistic investigations of Bile acid-Tamoxifen conjugates for Breast cancer therapy. Bioconjug Chem. 18, 2013; 24(9):1468-84.
(2013). Deciphering the role of charge, hydration, and hydrophobicity for cytotoxic activities and membrane interactions of bile acid based facial amphiphiles. Biophys. Biochim. Acta Biomembranes, (2013) 1828(8):1926-37.
(2012). 3, 4 dimethoxyphenyl bisbenzimidazole, a novel DNA Topoisomerase inhibitor that preferentially targets type IA Topoisomerase. Journal of Antimicrobial Chemotherapy, (2012) 67(12): 2882-2891.
(2011). Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates. International Journal of Antimicrobial Agents 37 (2011) 253-255.
(2010). Old class but new dimethoxy analogue of benzimidazole: a bacterial topoisomerase I inhibitor. International Journal of Antimicrobial Agents 35 (2010) 186-190.
(2007). Nuclear condensation and free radical scavenging: A dual mechanism of Bisbenzimidazoles to modulate radiation damage to DNA. Mol. Cell. Biochem. (2007) 305: 221-233.
(2006). Synthesis and in vitro cytotoxicity of haloderivatives of noscapine. Bioorganic & Medicinal Chemistry, 2006, Oct 1; 14(19): 6733-6.
Ratings and Comments
Total Projects Awarded:
Comments:
